NCT06495645 Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
| NCT ID | NCT06495645 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Gastric Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2024-11-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.
Eligibility Criteria
Inclusion Criteria: * Patients aged 40 or older * Scheduled for elective upper endoscopy Exclusion Criteria: * Pregnant women, * Inability to provide written informed consent * Prior gastrectomy, and * Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Contact & Investigator
Thomas Ka-Luen Lui
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06495645 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Gastric Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06495645 currently recruiting?
Yes, NCT06495645 is actively recruiting participants. Contact the research team at tkllui@hku.hk for enrollment information.
Where is the NCT06495645 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06495645 clinical trial?
NCT06495645 is sponsored by The University of Hong Kong. The principal investigator is Thomas Ka-Luen Lui at The University of Hong Kong. The trial plans to enroll 1,000 participants.